Crispr Therapeutics Ag (CRSP)

Income Tax Expense

$960.00K

Quarterly · Period ending: · USD

CRSP logo

CRSP Income Tax Expense

Latest reported$960.00K
CRSP Quarterly Income Tax (-$285.00K → $960.00K)
High-resolution chart · PNG

CRSP income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Income Tax Expense — Quarterly (USD)
Period endingIncome Tax Expense (USD)
960,000
839,000
614,000
619,000
1,292,000
1,109,000
700,000
876,000
1,287,000
724,000
233,000
412,000
923,000
1,320,000
-9,476,000
-575,000
6,118,000
3,608,000
2,252,999
-595,000
4,143,000
575,000
146,999
200,000
379,000
377,000
4,000
274,000
85,000
85,000
234,000
137,000
96,000
86,000
419,000
707,000
343,000
279,000
400,000
8,000
0
76,000
70,000
153,000
69,000
-285,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.